The news directly pertains to QuidelOrtho as JP Morgan has maintained a Neutral rating on the company and lowered the price target. This could potentially impact investor sentiment and the stock's short-term performance. However, the Neutral rating suggests that the stock's price is expected to perform in line with the market or sector average.